{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:10:09Z","timestamp":1790863809289,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"15","license":[{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Venous thromboembolism (VTE) prophylaxis is often overprescribed to patients at low risk for VTE. Whether risk assessment models (RAMs) reduce prescribing to low-risk patients is unknown. We incorporated a validated RAM into admission order sets to help physicians determine risk of VTE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To quantify RAM use, determine its association with prophylaxis, and identify patient factors associated with concordance between calculated VTE risk and prophylaxis use. We hypothesized that use of the RAM would be associated with less prophylaxis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Cross-sectional study. We excluded surgical, COVID, and intensive care unit patients, and patients with contraindication to prophylaxis or already on anticoagulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Medical inpatients aged \u226518 years admitted to 10 US hospitals from December 2020 to March 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Physician RAM use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Measures<\/jats:title>\n                    <jats:p>Physician prophylaxis prescription and patient characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Results<\/jats:title>\n                    <jats:p>\n                      Among 131,441 patient encounters, RAM use varied across hospitals from 54 to 99%. Overall, physician ordering was concordant with the RAM\u2019s recommendation for 68% of patients. Prophylaxis prescription was less common when the RAM was used than when it was not (44% vs. 73%,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001). When calculated risk was high (i.e., &gt;0.75%), 96% of patients had prophylaxis prescribed versus 37% when risk was low. Across hospitals, prophylaxis prescription rates varied more for low-risk (21 to 77%) than for high-risk patients (87 to 98%). Among low-risk patients, prophylaxis was associated with male sex, older age, reduced mobility, and history of DVT, stroke, heart or respiratory failure, or active cancer.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Use of the RAM was associated with reduced prophylaxis prescribing, but many low-risk patients still received prophylaxis, especially if they had a risk factor for VTE. Physicians appear to agree with high-risk assessments but are less comfortable not prescribing prophylaxis to patients at low risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11606-025-09592-6","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T17:20:43Z","timestamp":1746724843000},"page":"3649-3657","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Use of a Risk Assessment Model for Venous Thromboembolism Is Associated with Decreased Prophylaxis"],"prefix":"10.1007","volume":"40","author":[{"given":"Tarini","family":"Gunaratne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Schulte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg","family":"Lisheba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2063-1876","authenticated-orcid":false,"given":"Michael B.","family":"Rothberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,8]]},"reference":[{"issue":"4","key":"9592_CR1","doi-asserted-by":"publisher","first-page":"278","DOI":"10.7326\/0003-4819-146-4-200702200-00007","volume":"146","author":"F Dentali","year":"2007","unstructured":"Dentali F, Douketis JD, Gianni M, Lim W, Crowther MA. Meta-analysis: Anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients. Ann Intern Med. 2007;146(4):278-288.","journal-title":"Ann Intern Med."},{"key":"9592_CR2","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1182\/BLOODADVANCES.2018022954","volume":"2","author":"HJ Sch\u00fcnemann","year":"2018","unstructured":"Sch\u00fcnemann HJ, Cushman M, Burnett AE, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Adv. 2018;2:3198-3225. https:\/\/doi.org\/10.1182\/BLOODADVANCES.2018022954","journal-title":"Blood Adv."},{"issue":"2 Suppl","key":"9592_CR3","doi-asserted-by":"publisher","first-page":"e195S","DOI":"10.1378\/chest.11-2296","volume":"141","author":"SR Kahn","year":"2012","unstructured":"Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e195S-226S. https:\/\/doi.org\/10.1378\/chest.11-2296","journal-title":"Chest."},{"issue":"5","key":"9592_CR4","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/jhm.450","volume":"4","author":"GM Bump","year":"2009","unstructured":"Bump GM, Dandu M, Kaufman SR, Shojania KG, Flanders SA. How complete is the evidence for thromboembolism prophylaxis in general medicine patients? A meta-analysis of randomized controlled trials. J Hosp Med. 2009;4(5):289-97.","journal-title":"J Hosp Med."},{"issue":"14","key":"9592_CR5","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1001\/archinte.167.14.1476","volume":"167","author":"L Wein","year":"2007","unstructured":"Wein L, Wein S, Haas SJ, Shaw J, Krum H. Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients: A meta-analysis of randomized controlled trials. Arch Intern Med. 2007;167(14):1476-1486.","journal-title":"Arch Intern Med."},{"issue":"6","key":"9592_CR6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.12788\/jhm.2916","volume":"13","author":"JM Pavon","year":"2018","unstructured":"Pavon JM, Sloane RJ, Pieper CF, et al. Poor Adherence to Risk Stratification Guidelines Results in Overuse of Venous Thromboembolism Prophylaxis in Hospitalized Older Adults. J Hosp Med. 2018;13(6):403-404. https:\/\/doi.org\/10.12788\/jhm.2916","journal-title":"J Hosp Med."},{"issue":"9","key":"9592_CR7","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1007\/s11606-020-05993-x","volume":"36","author":"M Djulbegovic","year":"2021","unstructured":"Djulbegovic M, Chen K, Sureshanand S, Chaudhry S. Overuse of Primary Thromboprophylaxis in Medical Inpatients at Low Risk of Venous Thromboembolism. J Gen Intern Med. 2021;36(9):2883-2885. https:\/\/doi.org\/10.1007\/s11606-020-05993-x","journal-title":"J Gen Intern Med."},{"issue":"5","key":"9592_CR8","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1055\/s-0036-1597901","volume":"43","author":"S Barbar","year":"2017","unstructured":"Barbar S, Prandoni P. Scoring Systems for Estimating Risk of Venous Thromboembolism in Hospitalized Medical Patients. Semin Thromb Hemost. 2017;43(5):460-468. https:\/\/doi.org\/10.1055\/s-0036-1597901","journal-title":"Semin Thromb Hemost."},{"issue":"11","key":"9592_CR9","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1111\/j.1538-7836.2010.04044.x","volume":"8","author":"S Barbar","year":"2010","unstructured":"Barbar S, Noventa F, Rossetto V, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost. 2010;8(11):2450-7. https:\/\/doi.org\/10.1111\/j.1538-7836.2010.04044.x","journal-title":"J Thromb Haemost."},{"issue":"3","key":"9592_CR10","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1378\/chest.10-1944","volume":"140","author":"AC Spyropoulos","year":"2011","unstructured":"Spyropoulos AC, Anderson FA, Jr., Fitzgerald G, et al. Predictive and associative models to identify hospitalized medical patients at risk for VTE. Chest. 2011;140(3):706-14. https:\/\/doi.org\/10.1378\/chest.10-1944","journal-title":"Chest."},{"issue":"6","key":"9592_CR11","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001152","volume":"3","author":"D Rosenberg","year":"2014","unstructured":"Rosenberg D, Eichorn A, Alarcon M, McCullagh L, McGinn T, Spyropoulos AC. External validation of the risk assessment model of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) for medical patients in a tertiary health system. J Am Heart Assoc. 2014;3(6):e001152. https:\/\/doi.org\/10.1161\/JAHA.114.001152","journal-title":"J Am Heart Assoc."},{"key":"9592_CR12","doi-asserted-by":"publisher","DOI":"10.1055\/a-1698-6506","author":"MB Rothberg","year":"2021","unstructured":"Rothberg MB, Hamilton A, Greene MT, et al. Derivation and Validation of a Risk Factor Model to Identify Medical Inpatients at Risk for Venous Thromboembolism. Thrombosis Haemostasis. 2021;\u00a0https:\/\/doi.org\/10.1055\/a-1698-6506","journal-title":"Thrombosis and haemostasis."},{"key":"9592_CR13","doi-asserted-by":"publisher","unstructured":"Rothberg MB, Hamilton AC, Hu B, et al. Impact of Embedding a Venous Thromboembolism Risk Assessment Model in the Electronic Health Record Versus Usual Care: A Cluster-Randomized Trial. Circ Cardiovasc Qual Outcomes. 2024:e010359. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.123.010359","DOI":"10.1161\/CIRCOUTCOMES.123.010359"},{"issue":"6","key":"9592_CR14","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1111\/j.1538-7836.2010.03817.x","volume":"8","author":"MR Nendaz","year":"2010","unstructured":"Nendaz MR, Chopard P, Lovis C, et al. Adequacy of venous thromboprophylaxis in acutely ill medical patients (IMPART): multisite comparison of different clinical decision support systems. J Thromb Haemost. 2010;8(6):1230-4. https:\/\/doi.org\/10.1111\/j.1538-7836.2010.03817.x","journal-title":"J Thromb Haemost."},{"issue":"2","key":"9592_CR15","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s11239-007-0081-1","volume":"25","author":"S Baroletti","year":"2008","unstructured":"Baroletti S, Munz K, Sonis J, et al. Electronic alerts for hospitalized high-VTE risk patients not receiving prophylaxis: a cohort study. J Thromb Thrombolysis. 2008;25(2):146-50. https:\/\/doi.org\/10.1007\/s11239-007-0081-1","journal-title":"J Thromb Thrombolysis."},{"issue":"10","key":"9592_CR16","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1056\/NEJMoa041533","volume":"352","author":"N Kucher","year":"2005","unstructured":"Kucher N, Koo S, Quiroz R, et al. Electronic Alerts to Prevent Venous Thromboembolism among Hospitalized Patients. N Engl J Med. 2005;352(10):969-977.","journal-title":"N Engl J Med."},{"key":"9592_CR17","doi-asserted-by":"publisher","first-page":"205520762211188","DOI":"10.1177\/20552076221118828","volume":"8","author":"M Karajizadeh","year":"2022","unstructured":"Karajizadeh M, Hassanipour S, Sharifian R, Tajbakhsh F, Saeidnia HR. The effect of information technology intervention on using appropriate VTE prophylaxis in non-surgical patients: A systematic review and meta-analysis. Digit Health. 2022;8:20552076221118828. https:\/\/doi.org\/10.1177\/20552076221118828","journal-title":"Digit Health."},{"issue":"16","key":"9592_CR18","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1161\/CIRCULATIONAHA.108.841197","volume":"119","author":"G Piazza","year":"2009","unstructured":"Piazza G, Rosenbaum EJ, Pendergast W, et al. Physician Alerts to Prevent Symptomatic Venous Thromboembolism in Hospitalized Patients. Circulation. 2009;119(16):2196-2201.","journal-title":"Circulation."},{"issue":"8","key":"9592_CR19","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1001\/jamainternmed.2018.2022","volume":"178","author":"PJ Grant","year":"2018","unstructured":"Grant PJ, Conlon A, Chopra V, Flanders SA. Use of Venous Thromboembolism Prophylaxis in Hospitalized Patients. JAMA Internal Medicine. 2018;178(8):1122-1124. https:\/\/doi.org\/10.1001\/jamainternmed.2018.2022","journal-title":"JAMA Internal Medicine."},{"issue":"5","key":"9592_CR20","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jcjq.2022.02.004","volume":"48","author":"JL Holleck","year":"2022","unstructured":"Holleck JL, Jalbut MM, Rodwin BA, Chang JJ, Holleck ME, Merchant N. Improving Adherence to Risk Stratification Guidelines Regarding Venous Thromboembolism Prophylaxis. Jt Comm J Qual Patient Saf. 2022;48(5):301-303. https:\/\/doi.org\/10.1016\/j.jcjq.2022.02.004","journal-title":"Jt Comm J Qual Patient Saf."},{"key":"9592_CR21","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1055\/S-0041-1742227","volume":"6","author":"SR Moss","year":"2022","unstructured":"Moss SR, Martinez KA, Nathan C, Pfoh ER, Rothberg MB. Physicians\u2019 Views on Utilization of an Electronic Health Record-Embedded Calculator to Assess Risk for Venous Thromboembolism among Medical Inpatients: A Qualitative Study. TH Open Compan J Thromb Haemostasis. 2022;6:e33-e39. https:\/\/doi.org\/10.1055\/S-0041-1742227","journal-title":"TH open : companion journal to thrombosis and haemostasis."},{"key":"9592_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e3935","volume":"344","author":"MB Streiff","year":"2012","unstructured":"Streiff MB, Carolan HT, Hobson DB, et al. Lessons from the Johns Hopkins Multi-Disciplinary Venous Thromboembolism (VTE) Prevention Collaborative. Bmj. 2012;344:e3935. https:\/\/doi.org\/10.1136\/bmj.e3935","journal-title":"Bmj."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-09592-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-025-09592-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-09592-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T14:51:45Z","timestamp":1762959105000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-025-09592-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,8]]},"references-count":22,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["9592"],"URL":"https:\/\/doi.org\/10.1007\/s11606-025-09592-6","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,8]]},"assertion":[{"value":"22 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations:"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest:"}}]}}